There are 2867 resources available
Discussion
Presenter: All Speakers
Session: Management of adrenocortical carcinoma
Resources:
Webcast
303P - EO2401 (EO) therapeutic vaccine for patients (pts) with recurrent glioblastoma (GB): Phase I/II ROSALIE study
Presenter: David Reardon
Session: Poster session 03
1054P - Impact of intratumoral microbiome on immunotherapy treatment outcomes in patients with advanced non-small cell lung cancer
Presenter: Arielle Elkrief
Session: Poster session 15
1397P - Phase I results of exicorilant plus enzalutamide in patients with castration-resistant prostate cancer
Presenter: Mark Linch
Session: Poster session 11
304P - A phase II study of anlotinib in the treatment of recurrent high-grade glioma: Updated results
Presenter: Hui Dai
Session: Poster session 03
1055P - The gene landscape of lung adenocarcinoma patients with progressive disease of the leptomeninges
Presenter: hainan Yang
Session: Poster session 15
1398P - Overall survival (OS) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) who received prior androgen deprivation therapy (ADT) and reached low prostate-specific antigen (PSA) levels treated further with enzalutamide (ENZA): Post hoc analyses of ARCHES
Presenter: Daniel Petrylak
Session: Poster session 11
305P - The role of surgery in addition to chemotherapy in the second-line treatment of glioblastomas
Presenter: Ana Sofia Mendes
Session: Poster session 03
1056P - KRAS and LKB1 mutation conferring prognostic and predictive role on liquid biopsy in advanced NSCLC
Presenter: Achille Bottiglieri
Session: Poster session 15